Market Overview

UPDATE: Stifel Nicolaus Cuts PT to $46 on CIT Group on Fiscal Uncertainty, Reiterates Buy

Related CIT
CIT Serves as Sole Lead Arranger in $47M Add-On Acquisition Financing for Epic Health Services
Benzinga's Top Initiations

Stifel Nicolaus reiterated its Buy rating on CIT Group (NYSE: CIT) but reduced its price target from $47 to $46.

Stifel Nicolaus noted, "In our view, CIT shares remain attractive as the current valuation does not appropriately discount for the potential for improving growth and profitability. Although we expect the fiscal uncertainty to weigh on 4Q12 results, we expect CIT to finally receive regulatory relief in 1Q13, clearing the path to more aggressive capital allocation. With improving accounting clarity and improving visibility on tax benefits likely in 2013, we reiterate our Buy rating.Our $46 target price is based on 10x our new 2014 core EPS estimate."

CIT Group closed at $40.14 on Friday.

Latest Ratings for CIT

Oct 2015OppenheimerMaintainsOutperform
Aug 2015DA DavidsonInitiates Coverage onBuy
Jul 2015BarclaysMaintainsEqual-weight

View More Analyst Ratings for CIT
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (CIT)

Get Benzinga's Newsletters